Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Peloquin

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|February 27, 1999
Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacidsC A Peloquin, A E Bulpitt, G S Jaresko, et al.
Pharmacotherapy|December 17, 1998
Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacidsC A Peloquin, A E Bulpitt, G S Jaresko, et al.
Pharmacotherapy|January 1, 1994
Pharmacokinetic evaluation of para-aminosalicylic acid granulesC A Peloquin, T L Henshaw, G A Huitt, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamideC A Peloquin, G S Jaresko, C L Yong, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 1999
Once-daily and twice-daily dosing of p-aminosalicylic acid granulesC A Peloquin, S E Berning, G A Huitt, et al.
Tuberculosis (Edinburgh, Scotland)|October 3, 2002
Population pharmacokinetics of ethionamide in patients with tuberculosisM Zhu, R Namdar, J J Stambaugh, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 19, 2002
Ofloxacin population pharmacokinetics in patients with tuberculosisJ J Stambaugh, S E Berning, A E Bulpitt, et al.
Pharmacotherapy|July 1, 1994
Pharmacokinetic evaluation of aconiazide, a potentially less toxic isoniazid prodrugC A Peloquin, G T James, L D Craig, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2000
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variablesJ Q Tran, C H Ballow, A Forrest, et al.
The Journal of Infectious Diseases|December 1, 1993
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex diseaseS M Gordon, C R Horsburgh, C A Peloquin, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|February 27, 1999
Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacidsC A Peloquin, A E Bulpitt, G S Jaresko, et al.
Pharmacotherapy|December 17, 1998
Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacidsC A Peloquin, A E Bulpitt, G S Jaresko, et al.
Pharmacotherapy|January 1, 1994
Pharmacokinetic evaluation of para-aminosalicylic acid granulesC A Peloquin, T L Henshaw, G A Huitt, et al.
Antimicrobial Agents and Chemotherapy|January 7, 1998
Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamideC A Peloquin, G S Jaresko, C L Yong, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 1999
Once-daily and twice-daily dosing of p-aminosalicylic acid granulesC A Peloquin, S E Berning, G A Huitt, et al.
Tuberculosis (Edinburgh, Scotland)|October 3, 2002
Population pharmacokinetics of ethionamide in patients with tuberculosisM Zhu, R Namdar, J J Stambaugh, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 19, 2002
Ofloxacin population pharmacokinetics in patients with tuberculosisJ J Stambaugh, S E Berning, A E Bulpitt, et al.
Pharmacotherapy|July 1, 1994
Pharmacokinetic evaluation of aconiazide, a potentially less toxic isoniazid prodrugC A Peloquin, G T James, L D Craig, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2000
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variablesJ Q Tran, C H Ballow, A Forrest, et al.
The Journal of Infectious Diseases|December 1, 1993
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex diseaseS M Gordon, C R Horsburgh, C A Peloquin, et al.
Pageof 8